---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-003586"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T05:25:23.350350+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# agilon health appoints Diana L. McKenzie to Board of Directors

## Summary
- Appointed as Class II director effective February 17, 2023, term expiring at 2023 annual meeting.
- Will serve on Audit Committee and Compensation and Human Capital Committee.
- Former CIO at Workday (2016-2019), Amgen (2004-2016), and Eli Lilly (1987-2004).
- No related party transactions; compensation per existing non-employee director program.

## SEC filing metadata
- accession: 0000950170-23-003586
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017023003586/0000950170-23-003586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017023003586/agl-20230217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-003586
- JSON: https://secwatch.observer/filing/0000950170-23-003586.json
- Plain text: https://secwatch.observer/filing/0000950170-23-003586.txt

## Key facts
- Executive change
  Diana L. McKenzie was appointed as Class II director at agilon health, inc..
  - Action: appointed
  - Role: Class II director
  source text: Effective February 17, 2023, to fill a vacancy on the Board of Directors, Diana L. McKenzie was appointed to the Board as a Class II director in accordance with the Amended and Restated Certificate of Incorporation of agilon health, inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000095017023003586/0000950170-23-003586-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.